2017
DOI: 10.1371/journal.pone.0173944
|View full text |Cite
|
Sign up to set email alerts
|

Whole-genome sequencing suggests mechanisms for 22q11.2 deletion-associated Parkinson’s disease

Abstract: ObjectivesTo investigate disease risk mechanisms of early-onset Parkinson’s disease (PD) associated with the recurrent 22q11.2 deletion, a genetic risk factor for early-onset PD.MethodsIn a proof-of-principle study, we used whole-genome sequencing (WGS) to investigate sequence variants in nine adults with 22q11.2DS, three with neuropathologically confirmed early-onset PD and six without PD. Adopting an approach used recently to study schizophrenia in 22q11.2DS, here we tested candidate gene-sets relevant to PD… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
0
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 17 publications
(17 citation statements)
references
References 59 publications
(112 reference statements)
0
16
0
1
Order By: Relevance
“…In another recent article, the authors searched for genetic variants linking 22q11.2DS and PD using whole-genome sequencing analysis. The results provided preliminary evidence that the genome-wide burden of rare deleterious variants in genes functionally relevant to PD may collectively increase the likelihood of PD expression in the presence of the 22q11.2 deletion 9. Furthermore, in a few case reports, parkinsonism or EOPD preceded the diagnosis of 22q11.2DS 10 11…”
Section: Discussionmentioning
confidence: 85%
“…In another recent article, the authors searched for genetic variants linking 22q11.2DS and PD using whole-genome sequencing analysis. The results provided preliminary evidence that the genome-wide burden of rare deleterious variants in genes functionally relevant to PD may collectively increase the likelihood of PD expression in the presence of the 22q11.2 deletion 9. Furthermore, in a few case reports, parkinsonism or EOPD preceded the diagnosis of 22q11.2DS 10 11…”
Section: Discussionmentioning
confidence: 85%
“…This could be explained by smaller deletions, SNPs and/or translocations in this region that were not detected by any of the 3 techniques. Therefore, we recommend refining the diagnosis of those samples by whole-genome sequencing as suggested elsewhere [Guo et al, 2016;Butcher et al, 2017]. We believe that the integration of NGS alongside with aCGH in routine clinical genomic practice will allow more accurate and comprehensive clinical diagnosis.…”
Section: Discussionmentioning
confidence: 99%
“…Additional genetic and environmental factors that contribute to the increased PD risk in this group of patients are yet to be determined. A whole‐genome sequencing pilot study in patients with 22q11.2DS showed nominal enrichment in the PD cases of additional rare putatively damaging missense variants involving genome‐wide candidate genes with functional relevance to PD . Larger longitudinal studies are needed to improve prevalence estimates, and to evaluate how the interaction of lifestyle and additional environmental and genetic factors may contribute to lifetime risk of developing PD in 22q11.2DS …”
Section: Microdeletion 22q112: a Genetic Risk Factor For Pdmentioning
confidence: 99%
“…22q11.2DS-ASSOCIATED PD additional rare putatively damaging missense variants involving genome-wide candidate genes with functional relevance to PD. 25 Larger longitudinal studies are needed to improve prevalence estimates, and to evaluate how the interaction of lifestyle and additional environmental and genetic factors may contribute to lifetime risk of developing PD in 22q11.2DS. 1 Natural History of PD in 22q11.2 Deletion Syndrome PD in 22q11.2DS appears largely indistinguishable from idiopathic PD with respect to major clinical PD features.…”
Section: Reviewmentioning
confidence: 99%